# A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.

> **NCT04746105** · PHASE1 · COMPLETED · sponsor: **Taisho Pharmaceutical Co., Ltd.** · enrollment: 46 (actual)

## Conditions studied

- Patients with Mild Obstructive Sleep Apnea Hypopnea

## Interventions

- **DRUG:** TS-142
- **DRUG:** Dose-matched Placebo to TS-142

## Key facts

- **NCT ID:** NCT04746105
- **Lead sponsor:** Taisho Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-02-24
- **Primary completion:** 2021-10-30
- **Final completion:** 2021-10-30
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04746105

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04746105, "A Clinical Pharmacology Study of TS-142 in Patients with Obstructive Sleep Apnea Hypopnea.". Retrieved via AI Analytics 2026-05-29 from https://api.ai-analytics.org/clinical/NCT04746105. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*